Insurance policies in the United States may explain part of the outcome differences of adolescents and young adults with acute lymphoblastic leukemia treated on adult versus pediatric regimens

Blood

Volumn 113, Issue 8, 2009, Pages 1861-

  Kantarjian, Hagop M ^a   O'Brien, Susan ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; AGE DISTRIBUTION; CANCER SURVIVAL; HEALTH CARE POLICY; HEALTH INSURANCE; HEALTH PROGRAM; HUMAN; LETTER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REMISSION; RISK ASSESSMENT; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TREATMENT RESPONSE; UNITED STATES;

EID: 61849114567     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-10-186718     Document Type: Letter

References (1)

1. Stock W, La M, Sanford B, et al. What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies. Blood. 2008;112:1646-1654.